BAZ1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.783200E-01
Normal-vs-Stage2
6.634400E-01
Normal-vs-Stage3
2.211200E-01
Normal-vs-Stage4
7.046400E-01
Stage1-vs-Stage2
4.257000E-01
Stage1-vs-Stage3
5.874800E-01
Stage1-vs-Stage4
2.267000E-01
Stage2-vs-Stage3
1.787590E-01
Stage2-vs-Stage4
2.373800E-01
Stage3-vs-Stage4
9.427600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.368800E-01
Normal-vs-AfricanAmerican
7.997200E-01
Normal-vs-Asian
3.961000E-01
Caucasian-vs-AfricanAmerican
7.875800E-01
Caucasian-vs-Asian
5.411400E-01
AfricanAmerican-vs-Asian
5.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.790400E-01
Normal-vs-Female
5.522400E-01
Male-vs-Female
8.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.601000E-01
Normal-vs-Age(41-60Yrs)
8.883200E-01
Normal-vs-Age(61-80Yrs)
4.021600E-01
Normal-vs-Age(81-100Yrs)
7.060800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.847000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.474400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.729400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.662020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.444200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.037000E-01
Normal-vs-Daily Drinker
3.306600E-01
Normal-vs-Weekly Drinker
5.655000E-01
Normal-vs-Occasional Drinker
7.762200E-01
Normal-vs-Social Drinker
4.611800E-01
Non Drinker-vs-Daily Drinker
5.242000E-01
Non Drinker-vs-Weekly Drinker
9.933000E-01
Non Drinker-vs-Occasional Drinker
4.568000E-01
Non Drinker-vs-Social Drinker
8.660200E-01
Daily Drinker-vs-Weekly Drinker
6.625600E-01
Daily Drinker-vs-Occasional Drinker
2.696400E-01
Daily Drinker-vs-Social Drinker
4.975600E-01
Weekly Drinker-vs-Occasional Drinker
6.013400E-01
Weekly Drinker-vs-Social Drinker
9.009000E-01
Occasional Drinker-vs-Social Drinker
6.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.062200E-01
Normal-vs-Grade 2
3.935700E-02
Normal-vs-Grade 3
3.055600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.182960E-01
Grade 1-vs-Grade 3
3.087800E-02
Grade 1-vs-Grade 4
4.062200E-01
Grade 2-vs-Grade 3
1.838960E-01
Grade 2-vs-Grade 4
3.935700E-02
Grade 3-vs-Grade 4
3.055600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.949200E-01
Normal-vs-NonDiabetic
4.521400E-01
Diabetic-vs-NonDiabetic
7.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.311400E-01
Normal-vs-NoPancreatitis
4.897800E-01
Pancreatitis-vs-NoPancreatitis
2.253400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.580600E-01
Normal-vs-N1
6.427200E-01
N0-vs-N1
2.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.437400E-01
Normal-vs-TP53-NonMutant
3.406800E-01
TP53-Mutant-vs-TP53-NonMutant
2.488100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
